Tofacitinib
Intervention1 paper1 findingPubChem 9926791ChEBI 71200
- Cells1
Outcomes
1Chronic inflammation
downin human cells1
1 study
Chronic inflammation
downin human cells1
Tofacitinib decreases chronic inflammation in human cells.
Cellssustained IL-17/IL-22 stimulationskin3 weeks
Long-term human skin platform models chronic inflammation and senolytic treatments · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 29 Sep 2026
Latest
1CellsInflammaging
Long-term human skin platform models chronic inflammation and senolytic treatments
The culture platform maintained native tissue architecture for four weeks, revealing treatment effects on aged donor tissue that emerged only after prolonged exposure.